Robin Farmanfarmaian Bio
Robin Farmanfarmaian is a Silicon Valley based professional speaker and entrepreneur working in cutting edge tech poised to impact 100M people or more. Robin has been involved with over 20 early-stage biotech, healthcare, and educational startups.
Currently Farmanfarmaian is the co-founder and CEO of ChiroScript AI, a generative AI medical scribe for use in the clinic. She is also the co-founder of i-GENTIC, an autonomous AI platform that keeps corporations up to date and compliant with AI regulation. Previously, she has worked on medical devices including inhaled insulin, sleep apnea, XR, and co-founded the non-profit Organ Preservation Alliance that worked with DARPA, the DoD, and the White House to help fund scientists and create a scientific roadmap to solve cryopreservation and tissue engineering for organ transplants. Farmanfarmaian has also worked in early stage pharma, including with small molecules found using AI for drug discovery to cure cancer and treat autoimmune disease (p53 & AhR pathways).
She is an advisor to multiple companies, including: Cyphr, a VC fund focused on AI; Luxsonic Technologies, VR for radiologists; Alacrity Care, remote patient monitoring and data analytics for oncology; iSono Health, portable, AI driven ultrasound for breast cancer screening; and ConceptVines, a VC fund and product engineering firm focused on disruptive tech. Robin was also on an advisory council for ARPA-H, helping map out where ARPA-H can grant $1.5B into technically hard healthcare innovation.
With over 225 keynotes in 16 countries, she educates audiences on many aspects of technology intersecting healthcare, including artificial intelligence, longevity, and the shift in healthcare delivery to the patient’s home. She has written 4 books, including “The Patient as CEO: How Technology Empowers the Healthcare Consumer" (2015) and “How AI Can Democratize Healthcare: The Rise in Digital Care” (2022).
